Reviews anemia treatment in people with chronic kidney disease in China
Looks back at records of Chinese adults with kidney disease and anemia.
Plain-language title generated from the registry record
Registry title: A Real-World Study About Anemia in Chronic Kidney Disease in China（DASHENG）
Key facts
- Where
- Guangzhou, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with chronic kidney disease, including people on dialysis. It reviews past records of anemia and its treatment in China.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Chronic kidney disease, shown by a CKD diagnosis, a record of hemodialysis or peritoneal dialysis, or at least 2 eGFR measurements below 60 mL/min/1.73m² taken at least 3 months apart (not counting acute kidney injury)
Main reasons for not taking part
- Anemia from other causes, such as trauma, major bleeding, nutritional deficiency or hemolytic anemia
- Acute kidney disease without chronic kidney disease
- Missing key data: age, sex or visit dates
Read by machine on 9 November 2026.
Where in China
- First Affiliated Hospital, Sun Yat-Sen UniversityGuangzhou, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Wei Chen
- Trial code
- NCT07098416
- Record updated
- 1 August 2025
- Original description
Anemia affects the quality of life of CKD patients and increases the risk of CKD progression. we conducted a real-world study on patients with anemia in CKD to analyze the disease characteristics and treatment in Chinese patients with CKD-anemia.Read full original descriptionShow less
An In-Depth Analysis of the Present Diagnostic and Therapeutic Landscape for Renal Anemia in China's Real-World Clinical Environment: A Multicenter Retrospective Cohort Investigation（DASHENG Study）
Anemia affects the quality of life of CKD patients and increases the risk of CKD progression. we conducted a real-world study on patients with anemia in CKD to analyze the disease characteristics and treatment in Chinese patients with CKD-anemia.
Inclusion: diagnosis of CKD (e.g., "%chronic kidney disease%", "%chronic nephropathy%", "%renal failure%", "%nephritis%" for complete ICD-9/10 code mapping*); record of hemodialysis (HD) or peritoneal dialysis (PD) (refer to Attachment 2 for dialysis identification algorithms); ≥2 eGFR measurements <60 mL/min/1.73m² (calculated using CKD-EPI equation) with ≥3-month interval (excluding acute kidney injury).
Exclusion: Non-renal anemia due to trauma, traffic accidents, major hemorrhage, or other confirmed etiologies (e.g., acute hemorrhagic anemia, nutritional deficiency anemia, hemolytic anemia); Diagnosis of acute kidney disease (AKD) without chronic kidney disease (CKD) comorbidity; Incomplete critical data elements (including age, sex, or visit dates).